Personal information

Other IDs

ResearcherID: B-5995-2009
Scopus Author ID: 55942205400
Loop profile: 1159587

Countries

Czech Republic

Activities

Collapse all

Employment (5)

Elphogene, s.r.o.: Prague, CZ

2019-01-01 to present | CEO
Employment
Source: Self-asserted source
Marek Minarik

Watrex Praha: Prague, CZ

2015-10 to present | Director
Employment
Source: Self-asserted source
Marek Minarik

Faculty of Sciences/ Charles University in Prague: Prague, CZ

2013 to present | Assistant professor (Institute for Analytical Chemistry)
Employment
Source: Self-asserted source
Marek Minarik

1st Faulty of Medicine/Charles University in Prague: Prague, CZ

2013 to 2019-12-31 | Senior scientist (Department of Internal Medicine)
Employment
Source: Self-asserted source
Marek Minarik

Genomac research institute: Prague, CZ

2013 to 2018-12-31 | Director (Center for applied Genomics of Solid Tumors (CEGES))
Employment
Source: Self-asserted source
Marek Minarik

Education and qualifications (2)

Northeastern University: Boston, MA, US

1995-09 to 2000-05 | Ph.D. (Barnett Institute of Chemical and Biological Analysis)
Education
Source: Self-asserted source
Marek Minarik

Charles University in Prague, Faculty of Sciences: Prague, CZ

1989-09 to 1994-05 | M.S. (Institute for Physical and Macromolecular Chemistry)
Education
Source: Self-asserted source
Marek Minarik

Professional activities (4)

International society of liquid biopsy: Granada, ES

2022-11 to present | Regular
Membership
Source: Self-asserted source
Marek Minarik

American Association for Cancer Research: PA, PA, US

2016 to present | Regular
Membership
Source: Self-asserted source
Marek Minarik

Academic Assembly of Czech Academy of Sciences: Prague, CZ

2014-04-24 to present | Elected
Membership
Source: Self-asserted source
Marek Minarik

International Society for Forensic Genetics: New York, NY, US

2008 to present | Regular
Membership
Source: Self-asserted source
Marek Minarik

Funding (14)

Portable instrument for detection of methanol intoxication.

2014-01-01 to 2017-12-31 | Grant
Technology Agency of the Czech Republic (Prague, CZ)
URL: https://grants.uberresearch.com/501100002969/TA04010463/Portable-instrument-for-detection-of-methanol-intoxication
GRANT_NUMBER: TA04010463
Source: Self-asserted source
Marek Minarik via DimensionsWizard

Epigenetic markers influencing the behavior of brain tumors

2013-01-01 to 2015-12-31 | Grant
Ministry of Health (Prague, CZ)
URL: https://grants.uberresearch.com/501100003243/NT14253/Epigenetic-markers-influencing-the-behavior-of-brain-tumors
GRANT_NUMBER: NT14253
Source: Self-asserted source
Marek Minarik via DimensionsWizard

OncoDetect - system for early detection of cancer markers in peripheral blood of patients

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Quality evaluation of multimodal treatment in patients with colorectal liver metastatic disease: Mutlicentric study within Czech complex oncology centres

Source: Self-asserted source
Marek Minarik via DimensionsWizard

The clinical significance of epigenetic factors for improvement of diagnosis, assessment of prognosis and the risk of recurrence after curative resection for pancreatic cancer.

Source: Self-asserted source
Marek Minarik via DimensionsWizard

New possibilities for application of molecular-diagnostic methods for early detection and proper therapy selection of progressing Non-Small Cell Lung Cancer based on detection and monitoring of hypermethylation of specific genes

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Resistance to antiplatelet agents, its etiology and the possibility of its affection

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Use of New Molecular Genetic Methods for the Early Detection of Disease Progression in Patients with Resectable, Primary Colorectal Carcinoma Based On Circulating Tumor Cells and Free Tumor Nucleic Acids.

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Clinical and functional correlates of hypertrophic cardiomyopathy in Czech population

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Research a development of a novel protein microseparator.

2007-01-01 to 2009-12-31 | Grant
Ministry of Industry and Trade (Prague, CZ)
URL: https://grants.uberresearch.com/501100004578/FI-IM4%252F074/Research-a-development-of-a-novel-protein-microseparator
GRANT_NUMBER: FI-IM4/074
Source: Self-asserted source
Marek Minarik via DimensionsWizard

Research, development and implementation of technology for manufacturing of DNA diagnostic kits.

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Use of molecular predictors for optimum selection of targeted therapy of non-small cell lung cancer

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Detection and analysis of genomic variations in selected oncogenes and tumor supressor genes in patients with chronic pancreatitis and pancreatic cancer and their use in early diagnostic and therapeutic process.

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Identification of inherited DNA polymorphisms in genes of testosterone synthetic pathway as factors of genetic predisposition to development of prostate cancer and their use in prevention and prognosis in Czech population

Source: Self-asserted source
Marek Minarik via DimensionsWizard

Works (50 of 128)

Items per page:
Page 1 of 3

3D-printed device for time- and cost-efficient sample preparation and DNA fractionation

Talanta
2025-05 | Journal article
DOI: 10.1016/j.talanta.2024.127461
Contributors: Helena Hrušková; Roman Řemínek; Marek Minarik; Doo Soo Chung; František Foret
Source: check_circle
Crossref

Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer

Genes
2024-10-07 | Journal article
DOI: 10.3390/genes15101302
Contributors: Tereza Hálková; Bohuš Bunganič; Eva Traboulsi; Marek Minárik; Miroslav Zavoral; Lucie Benešová
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Improvement of oligonucleotide separation using a repetto high‐performance liquid chromatography recycling approach

Journal of Separation Science
2024-06 | Journal article
DOI: 10.1002/jssc.202400252
Contributors: Barbora Fiserova; Milan Minarik; Michal Nahunek; Roman Kysilka; Marek Minarik
Source: check_circle
Crossref

Circulating Tumor DNA correlates with Lactate Dehydrogenase, CYFRA 21-1, and CRP levels in patients with advanced NSCLC

Journal of Cancer
2023 | Journal article
DOI: 10.7150/jca.78574
Part of ISSN: 1837-9664
Contributors: Marcela Buresova; Lucie Benesova; Marek Minarik; Renata Ptackova; Tereza Halkova; Petr Hosek; Jan Baxa; Milos Pesek; Martin Svaton; Ondrej Fiala
Source: Self-asserted source
Marek Minarik

Combination of Circulating Tumour DNA and <sup>18</sup>F-FDG PET/CT for Precision Monitoring of Therapy Response in Patients With Advanced Non-small Cell Lung Cancer: A Prospective Study

Cancer Genomics - Proteomics
2022 | Journal article
DOI: 10.21873/cgp.20319
Part of ISSN: 1109-6535
Part of ISSN: 1790-6245
Contributors: ONDREJ FIALA; JAN BAXA; MARTIN SVATON; LUCIE BENESOVA; RENATA PTACKOVA; TEREZA HALKOVA; MAREK MINARIK; PETR HOSEK; MARCELA BURESOVA; JINDRICH FINEK et al.
Source: Self-asserted source
Marek Minarik

Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis

Pathology and Oncology Research
2022-06-28 | Journal article
DOI: 10.3389/pore.2022.1610308
Part of ISSN: 1532-2807
Contributors: Lucie Benesova; Renata Ptackova; Tereza Halkova; Anastasiya Semyakina; Martin Svaton; Ondrej Fiala; Milos Pesek; Marek Minarik
Source: Self-asserted source
Marek Minarik

Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma

Cancers
2022-06-07 | Journal article | Author
DOI: 10.3390/cancers14122823
Part of ISSN: 2072-6694
Contributors: Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondrej Majek; Jan Bureš; Miroslav Zavoral et al.
Source: Self-asserted source
Marek Minarik

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

Frontiers in Oncology
2020-07-24 | Journal article
DOI: 10.3389/fonc.2020.01028
Part of ISSN: 2234-943X
Source: Self-asserted source
Marek Minarik
grade
Preferred source (of 2)‎

Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer

Pathology & Oncology Research
2020-01-25 | Journal article
DOI: 10.1007/s12253-018-0490-9
Contributors: Lucie Benesova; Tereza Halkova; Bohus Bunganic; Barbora Belsanova; Miroslav Zavoral; Eva Traboulsi; Marek Minarik
Source: check_circle
Crossref

Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

World Journal of Gastroenterology
2019-12-28 | Journal article
DOI: 10.3748/wjg.v25.i48.6939
Part of ISSN: 1007-9327
Source: Self-asserted source
Marek Minarik

Application of denaturing capillary electrophoresis for the detection of prognostic mutations in isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 genes in brain tumors

Journal of Separation Science
2018-07 | Journal article
DOI: 10.1002/jssc.201701473
Contributors: Lucie Benesova; Barbora Belsanova; Filip Kramar; Tereza Halkova; Vladimir Benes; Marek Minarik
Source: check_circle
Crossref

Serum Concentration of Erlotinib and its Correlation with Outcome and Toxicity in Patients with Advanced-stage NSCLC.

Anticancer research
2017-11 | Journal article
PMID: 29061834
Contributors: Fiala O; Hosek P; Pesek M; Finek J; Racek J; Stehlik P; Sorejs O; Minarik M; Benesova L; Celer A et al.
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

[KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass].

Casopis lekaru ceskych
2016 | Journal article
PMID: 26898792
Contributors: Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M et al.
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC

Anticancer research
2016 | Journal article
EID:

2-s2.0-84973410628
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Minarik, M.; Benesova, L.; Sorejs, O.; Svaton, M.; Bortlicek, Z.; Kucera, R.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

IDH1/2 mutation and MGMT promoter methylation - The relevant survival predictors in Czech patients with brain Gliomas

Folia Biologica (Czech Republic)
2016 | Journal article
EID:

2-s2.0-85007145671
Contributors: Kramář, F.; Minárik, M.; Benešová, L.; Halková, T.; Netuka, D.; Bradáč, O.; Beneš, V.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas.

Folia biologica
2016 | Journal article
PMID: 27978414
Contributors: Kramář F; Minárik M; Benešová L; Halková T; Netuka D; Bradáč O; Beneš V
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Longitudinal molecular characterization of endoscopic specimens from colorectal lesions

World Journal of Gastroenterology
2016 | Journal article
DOI: 10.3748/wjg.v22.i20.4936
EID:

2-s2.0-84979021669
Contributors: Minarikova, P.; Benesova, L.; Halkova, T.; Belsanova, B.; Suchanek, S.; Cyrany, J.; Tuckova, I.; Bures, J.; Zavoral, M.; Minarik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Molecular profiling of lung cancer | Molekulární profilování nádorů plic

Onkologie (Czech Republic)
2016 | Journal article
EID:

2-s2.0-84974593916
Contributors: Minárik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Monitoring of circulating tumor cells by a combination of immunomagnetic enrichment and RT-PCR in colorectal cancer patients undergoing surgery

Advances in Clinical and Experimental Medicine
2016 | Journal article
DOI: 10.17219/acem/63824
EID:

2-s2.0-85006837017
Contributors: Vojtechova, G.; Benesova, L.; Belsanova, B.; Minarikova, P.; Levy, M.; Lipska, L.; Suchanek, S.; Zavoral, M.; Minarik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene

Anticancer research
2016 | Journal article
EID:

2-s2.0-84973410369
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Svaton, M.; Minarik, M.; Benesova, L.; Bortlicek, Z.; Kucera, R.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers

Gastroenterology Research and Practice
2016 | Journal article
DOI: 10.1155/2016/9408190
Contributors: Petra Minarikova; Lucie Benesova; Tereza Halkova; Barbora Belsanova; Inna Tuckova; Frantisek Belina; Ladislav Dusek; Miroslav Zavoral; Marek Minarik
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib

Neoplasma
2016 | Journal article
DOI: 10.4149/318_151001N512
EID:

2-s2.0-84969645856
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Racek, J.; Minarik, M.; Benesova, L.; Bortlicek, Z.; Sorejs, O.; Kucera, R.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

The prognostic role of kras mutation in patients with advanced NSCLC treated with second-or third-line chemotherapy

Anticancer Research
2016 | Journal article
EID:

2-s2.0-84991721108
Contributors: Svaton, M.; Fiala, O.; Pesek, M.; Bortlicek, Z.; Minarik, M.; Benesova, L.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Utility of a panel of gene mutations and amplifications for estimation of prognosis in patients with gastric cancer | Využití panelu somatických genových mutací a amplifikací pro odhad prognózy pacientů s karcinomem žaludku

Gastroenterologie a Hepatologie
2016 | Journal article
DOI: 10.14735/amgh2016244
EID:

2-s2.0-84979043540
Contributors: Benešová, L.; Mináriková, P.; Hálková, T.; Belšánová, B.; Suchánek, Š.; Bělina, F.; Dušek, L.; Jarkovský, J.; Zavoral, M.; Minárik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature

Gastrointestinal Endoscopy
2016-10 | Journal article
DOI: 10.1016/j.gie.2016.06.023
Contributors: Rudolf Repak; Darina Kohoutova; Miroslav Podhola; Stanislav Rejchrt; Marek Minarik; Lucie Benesova; Michal Lesko; Jan Bures
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Change in Serum Lactate Dehydrogenase Is Associated with Outcome of Patients with Advanced-stage NSCLC Treated with Erlotinib.

Anticancer research
2016-05 | Journal article
PMID: 27127158
Contributors: Fiala O; Pesek M; Finek J; Topolcan O; Racek J; Svaton M; Kucera R; Minarik M; Benesova L; Bortlicek Z et al.
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy.

Anticancer research
2016-03 | Journal article
PMID: 26977001
Contributors: Svaton M; Fiala O; Pesek M; Bortlicek Z; Minarik M; Benesova L; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Epidermal Growth Factor Receptor Gene Amplification in Patients with Advanced-stage NSCLC.

Anticancer research
2016-01 | Journal article
PMID: 26722081
Contributors: Fiala O; Pesek M; Finek J; Minarik M; Benesova L; Sorejs O; Svaton M; Bortlicek Z; Kucera R; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.

Anticancer research
2016-01 | Journal article
PMID: 26722080
Contributors: Fiala O; Pesek M; Finek J; Svaton M; Minarik M; Benesova L; Bortlicek Z; Kucera R; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib

Tumor Biology
2015 | Journal article
DOI: 10.1007/s13277-015-3660-3
EID:

2-s2.0-84952870583
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Topolcan, O.; Racek, J.; Minarik, M.; Benesova, L.; Bortlicek, Z.; Poprach, A.; Buchler, T.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

MicroRNAs in Pancreatic Cancer: Involvement in Carcinogenesis and Potential Use for Diagnosis and Prognosis

Gastroenterology Research and Practice
2015 | Journal article
DOI: 10.1155/2015/892903
Contributors: Tereza Halkova; Romana Cuperkova; Marek Minarik; Lucie Benesova
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Personalized cancer treatment of patients with advanced-stage NSCLC | Personalizace onkologické léčby pacientů s pokročilým stadiem NSCLC

Studia Pneumologica et Phthiseologica
2015 | Journal article
EID:

2-s2.0-84941585426
Contributors: Fiala, O.; Pešek, M.; Teřl, M.; Fínek, J.; Minárik, M.; Topolčan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Statins augment efficacy of EGFR-TKIs in patients with advanced-stage non-small cell lung cancer harbouring KRAS mutation

Tumor Biology
2015 | Journal article
DOI: 10.1007/s13277-015-3249-x
EID:

2-s2.0-84940438804
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Minarik, M.; Benesova, L.; Bortlicek, Z.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Variants in miRNA regulating cardiac growth are not a common cause of hypertrophic cardiomyopathy

Cardiology (Switzerland)
2015 | Journal article
DOI: 10.1159/000369247
EID:

2-s2.0-84921916979
Contributors: Curila, K.; Benesova, L.; Tomasov, P.; Belsanova, B.; Widimsky, P.; Minarik, M.; Zemanek, D.; Veselka, J.; Gregor, P.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Clinical and morphological variables influencing the results of genetic testing of patients with hypertrophic cardiomyopathy.

Experimental and Clinical Cardiology
2014 | Journal article
EID:

2-s2.0-84896751869
Contributors: Tomasov, P.; Minarik, M.; Zemanek, D.; Cadova, P.; Benesova, L.; Belsanova, B.; Veselka, J.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Colorectal cancer prevention in the Czech Republic: Time trends in performance indicators and current situation after 10 years of screening

European Journal of Cancer Prevention
2014 | Journal article
DOI: 10.1097/CEJ.0b013e328364f203
EID:

2-s2.0-84889250860
Contributors: Suchanek, S.; Majek, O.; Vojtechova, G.; Minarikova, P.; Rotnaglova, B.; Seifert, B.; Minarik, M.; Kozeny, P.; Dusek, L.; Zavoral, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Colorectal cancer screening: 20 years of development and recent progress

World Journal of Gastroenterology
2014 | Journal article
DOI: 10.3748/wjg.v20.i14.3825
EID:

2-s2.0-84898403521
Contributors: Zavoral, M.; Suchanek, S.; Majek, O.; Fric, P.; Minarikova, P.; Minarik, M.; Seifert, B.; Dusek, L.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy

Folia Biologica (Czech Republic)
2014 | Journal article
EID:

2-s2.0-84896281915
Contributors: Tomašov, P.; Minárik, M.; Zemánek, D.; Čadová, P.; Homolová, S.; Čurila, K.; Pěnička, M.; Benešová, L.; Belšánová, B.; Gregor, P. et al.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Genetic testing in the management of relatives of patients with hypertrophic cardiomyopathy.

Folia biologica
2014 | Journal article
PMID: 24594054
Contributors: Tomašov P; Minárik M; Zemánek D; Čadová P; Homolová S; Čurilka K; Pěnička M; Benešová L; Belšánová B; Gregor P et al.
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Predictive and prognostic significance of sodium levels in patients with NSCLC treated by Erlotinib

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84918526903
Contributors: Svaton, M.; Fiala, O.; Pesek, M.; Bruha, F.; Mukensnabl, P.; Racek, J.; Minarik, M.; Bortlicek, Z.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84906308995
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Benesova, L.; Minarik, M.; Bortlicek, Z.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Retreatment with erlotinib of a patient with metastatic NSCLC harboring EGFR mutation: A case report

Tumori
2014 | Journal article
DOI: 10.1700/1578.17234
EID:

2-s2.0-84921627816
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Krakorova, G.; Benesova, L.; Minarik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

The role of Neuron-specific Enolase (NSE) and Thimidine Kinase (TK) levels in prediction of efficacy of EGFR-TKIs in patients with advanced-stage NSCLC

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84908680715
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Benesova, L.; Minarik, M.; Bortlicek, Z.; Topolcan, O.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Toward Male Individualization with Rapidly Mutating Y-Chromosomal Short Tandem Repeats

Human Mutation
2014 | Journal article
DOI: 10.1002/humu.22599
EID:

2-s2.0-84904433303
Contributors: Ballantyne, K.N.; Ralf, A.; Aboukhalid, R.; Achakzai, N.M.; Anjos, M.J.; Ayub, Q.; Balažic, J.; Ballantyne, J.; Ballard, D.J.; Berger, B. et al.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier

Predictive and prognostic significance of sodium levels in patients with NSCLC treated by erlotinib.

Anticancer research
2014-12 | Journal article
PMID: 25503188
Contributors: Svaton M; Fiala O; Pesek M; Bruha F; Mukensnabl P; Racek J; Minarik M; Bortlicek Z
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

P18. Predictive role of serum tumor markers NSE and TK in patients with advanced-stage NSCLC treated with EGFR-TKIs.

Translational lung cancer research
2014-10 | Journal article
PMC: PMC4367793
Contributors: Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

P20. The role of statins in patients with advanced NSCLC harboring KRAS mutation treated with EGFR-TKIs.

Translational lung cancer research
2014-10 | Journal article
PMC: PMC4367782
Contributors: Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

The role of neuron-specific enolase (NSE) and thymidine kinase (TK) levels in prediction of efficacy ofEGFR-TKIs in patients with advanced-stage NSCLC [corrected].

Anticancer research
2014-09 | Journal article
PMID: 25202114
Contributors: Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.

Anticancer research
2014-06 | Journal article
PMID: 24922695
Contributors: Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
Source: Self-asserted source
Marek Minarik via Europe PubMed Central

Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC

Neoplasma
2013 | Journal article
DOI: 10.4149/neo_2013_055
EID:

2-s2.0-84880430910
Contributors: Fiala, O.; Pesek, M.; Finek, J.; Benesova, L.; Bortlicek, Z.; Minarik, M.
Source: Self-asserted source
Marek Minarik via Scopus - Elsevier
Items per page:
Page 1 of 3
How many people are using ORCID?